Compare Supplements

284 mg (300 mg inclisiran sodium) by subcutaneous injection administered by a healthcare professional on day 1, again at day 90 (month 3), then every 6 months thereafter. A prescription drug; this is the approved regimen, not a self-directed supplement protocol.

Any time

Prefilled subcutaneous injection (inclisiran 284 mg)

500mg

Morning · with food (preferred)

Nicotinamide Riboside Chloride capsules or powder

• Known hypersensitivity to inclisiran or excipients
• Not a substitute for a clinician's evaluation — prescription drug only

• Statins / ezetimibe
• PCSK9 monoclonal antibodies (evolocumab / alirocumab)

• Known hypersensitivity to nicotinamide riboside or niacin derivatives
• Active cancer or cancer history: NAD+ elevation may theoretically support tumor cell metabolism (consult oncologist before use)
• Severe hepatic impairment: high-dose NAD+ precursors may affect liver metabolism

• Chemotherapy agents
• PARP inhibitors (e.g., olaparib, niraparib)
• Alcohol